A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)
Clinical trial NCT00279747 · COMPLETED
Trial details
- NCT number
- NCT00279747
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-09-01
- Primary completion
- 2003-01-01
- Enrollment
- 226
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.